From: Fauci, Anthony (NIH/NIAID) [E]

Sent: Thu, 30 Apr 2020 22:37:05 +0000
To: Hahn, Stepher;Debi Birx;Redfield, Robert R. (CDC/OD);Verma, Seema (CMS/OA)
Subject: RE: Serology Studies in Germany

Thanks, Steve!

Anthony S. Fauci, MD

Director

National Institute of Allergy and Infectious Diseases
Building 31, Room 7A-03

31 Center Drive, MSC 2520

National Institutes of Health

Bethesda, MD a

Phone:
FAX: (307 1561408
E-mail: f
The information in this e-mail and any of its attachments is confidential and may contain sensitive
information. it should not be used by anyone who is not the original intended recipient. If you
have received this e-mail in error please inform the sender and delete it from your mailbox or any
other storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall not
accept liability for any statements made that are the sender's own and not expressly made on
behalf of the NIAID by one of its representatives.

 

 

From: Hahn, Stephenf—____ 0) Gf>

Sent: Thursday, April 30, 2020 6:34 PM

To: Debi Birx("0) GF>; Redfield, Robert R. (CDC/OD) Fy 6)
Seema (CMS/OA) __________.) ©}>; Fauci, Anthony (NIH/NIAID) [E]

(XC)

Subject: Fwd: Serology Studies in Germany

   

Interesting information from Germany

From: Shuren, Jeff (0 6)>

Date: April 30, 2020 at 5:46:27 PM EDT

To: Hahn, Stephen OJ >, Shah, Anand[ >, Lenihan, Keagan
CO >, Guram, Jeet {IO} 6}>, Rom, Colin
Ce

Subject: Serology Studies in Germany

FYSA regarding serology studies being conducted in Germany, including status of tests to be used for
those studies. This is the follow up to what I sent you last week. 75}

ES |

 

 
